# Structured Dashboard: ABRIDGE

Generated: 2025-11-05T18:56:51.329162
Source: Structured Payload (data/payloads/abridge.json)

---

## Company Overview
- **Legal Name:** Abridge
- **Website:** [abridge.com](https://www.abridge.com/)
- **Headquarters:** Pittsburgh, PA, USA
- **Founded Year:** 2019
- **Categories:** Generative AI, Healthcare Technology, Clinical Documentation, AI for Healthcare, Natural Language Processing

## Business Model and GTM
- **Active Products:**
  - Abridge AI Platform: Generative AI Platform for Clinical Conversations, providing clinically useful and billable AI notes at the point of care, integrated directly into EHR workflows.
  - Abridge Contextual Reasoning Engine: Leading healthcare AI infrastructure, powering the most trusted billable, clinically useful, and compliant notes at the point of care.
- **Pricing Tiers:** Free, Pro, Enterprise
- **Notable Customers:** Johns Hopkins, Kaiser Permanente, Duke, Mayo Clinic
- **Hiring Focus:** Engineering, Sales, Product, Marketing

## Funding & Investor Profile
- **Total Raised:** $0.0
- **Last Disclosed Valuation:** $0.0
- **Last Round Name:** Series A
- **Last Round Date:** August 12, 2025
- **Funding Events:**
  - April 10, 2025: Sharp HealthCare Chooses Abridge for Clinical Documentation
  - April 29, 2025: Partnership with AltaMed Health Services Corporation
  - August 12, 2025: Funding announcement for Real Time Prior Authorization

## Growth Momentum
- **Total Headcount:** 100
- **Headcount Growth Rate:** 50.0%
- **Job Openings Count:** 15
- **Headcount Velocity:** Rapid
- **Products Released in Last 12 Months:** 3
- **Geography Expansion:** Europe, Asia-Pacific
- **Geography Expansion Rate:** Moderate
- **Customer Quality Score:** Enterprise
- **Positive Signals:**
  - Partnership with Kaiser Permanente
  - Named Market Leader in Ambient AI KLAS Report
  - #1 Most Innovative in Healthcare by Fast Company

## Visibility & Market Sentiment
- **Transparency Score:** 92.0 (High)
- **Marketing Claims:** 
  - The company states it offers enterprise-grade AI for clinical conversations.
  - The company states it measurably improves outcomes for clinicians.
- **Actual Case Studies:** Case study with Johns Hopkins, Customer testimonial from Mayo Clinic
- **Negative Signals:** Not disclosed.

## Risks and Challenges
- **Key Challenges:**
  - Market competition
  - Regulatory compliance
- **Risk Score:** 31.0 (Medium)
- **Leadership Stability:** Stable
- **Leadership Changes in Last 12 Months:** 1
- **Layoffs Mentioned:** No

## Outlook
- The company is positioned in a growing sector of healthcare technology with a strong focus on generative AI. With notable partnerships and a solid customer base, Abridge appears to be on a positive trajectory. However, it must navigate market competition and regulatory challenges to sustain growth.

## Disclosure Gaps
- Claims enterprise customers but no case studies.
- Revenue not disclosed.
- Customer count not available.